Gadofosveset (Vasovist, Bayer Schering Pharma AG, Berlin/Germany) is the first intravascular contrast agent approved for use with magnetic resonance angiography in the European Union, Switzerland, Turkey, Canada, and Australia. Gadofosveset reversibly binds to albumin providing extended intravascular enhancement compared wth existing extracellular magnetic resonance contrast agents. Prior to ap...

With technological advances in magnetic resonance angiography (MRA), spatial resolution of 1-mm perforating vessels can reliably be visualized and accurately located in reference to patients' anatomic landmarks without exposing patients to ionizing radiation or iodinated contrast, resulting in optimal perforator selection, improved flap design, and increased surgical efficiency. As their experi...

PURPOSE In a case with moyamoya disease, we found the magnetic resonance image and magnetic angiographic studies were helpful for the definite diagnosis of the disease. CASE REPORT A young adult presented limb-shaking transient ischemic attacks caused by moyamoya disease. The magnetic resonance angiography proved the steno-occlusive lesions in the major arteries of circle of Willis, and the m...

BACKGROUND Diagnosing pulmonary embolism may be difficult, because there is no reliable noninvasive imaging method. We compared a new noninvasive method, gadolinium-enhanced pulmonary magnetic resonance angiography, with standard pulmonary angiography for diagnosing pulmonary embolism. METHODS A total of 30 consecutive patients with suspected pulmonary embolism underwent both standard pulmona...